Načítá se...
Utilizing BMP-2 muteins for treatment of multiple myeloma
Multiple myeloma (MM) represents a haematological cancer characterized by the pathological hyper proliferation of antibody-producing B-lymphocytes. Patients typically suffer from kidney malfunction and skeletal disorders. In the context of MM, the transforming growth factor β (TGFβ) member Activin A...
Uloženo v:
Vydáno v: | PLoS One |
---|---|
Hlavní autoři: | , , , , , , , |
Médium: | Artigo |
Jazyk: | Inglês |
Vydáno: |
Public Library of Science
2017
|
Témata: | |
On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5425150/ https://ncbi.nlm.nih.gov/pubmed/28489849 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0174884 |
Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|